Estimate Recalculated Sep 9, 2024 12:24AM EST
Eric Lefebvre has an estimated net worth of $7.67 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., PLIANT THERAPEUTICS, INC., and Regado Biosciences Inc.
Eric Lefebvre's CIK is 0001614741
2023 was Eric Lefebvre's most active year for acquiring shares with 5 total transactions. Eric Lefebvre's most active month to acquire stocks was the month of December. 2021 was Eric Lefebvre's most active year for disposing of shares, totalling 5 transactions. Eric Lefebvre's most active month to dispose stocks was the month of February. 2022 saw Eric Lefebvre paying a total of $0.00 for 276,876 shares, this is the most they've acquired in one year. In 2023 Eric Lefebvre cashed out on 101,066 shares for a total of $3,027,838.14, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!